Clay Thorp

-

Director Information, Funds, Firms

Home | Sign Up | Log In
⚲
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Clay Thorp
Firm
Address280 S Mangum St Suite 350
Durham, NC 27701
Source
Associated Funds Form D Role 2011 - 2026 Raised AUM
Healthcare Innovations Venture Fund LLC 021-591483 Executive Officer
25.0 M
of 125.0 M
PIPR Therapeutics Inc 021-563664 Director
1.5 M
of 2.5 M
Genecentric Therapeutics Inc 021-549421 Director
2.0 M
of 5.0 M
Genecentric Therapeutics Inc 021-459294 Director
2.5 M
of 3.5 M
Genecentric Therapeutics Inc 021-416162 Director
4.5 M
of 7.5 M
Vigil Neuroscience Inc 021-411167 Director
90.0 M
of 90.0 M
Stridebio Inc 021-393667 Director
48.9 M
of 81.5 M
Genecentric Therapeutics Inc 021-386126 Director
1.2 M
of 1.2 M
Vigil Neuroscience Inc 021-377071 Director
50.0 M
of 50.0 M
ORIG3N Inc 021-375084 Director
26.2 M
of 28.7 M
Clearside Biomedical Inc 021-354771 Director
3.3 M
of 3.3 M
Lysosomal Therapeutics Inc 021-352903 Director
1.0 M
of 3.0 M
PhaseBio Pharmaceuticals Inc 021-320911 Director
26.0 M
of 32.1 M
Stridebio Inc 021-314778 Director
7.7 M
of 15.8 M
PhaseBio Pharmaceuticals Inc 021-279697 Director
6.6 M
of 7.9 M
Genecentric Diagnostics Inc 021-277741 Director
6.1 M
of 8.6 M
Clearside Biomedical Inc 021-272373 Director
0.3 M
of 0.3 M
Lysosomal Therapeutics Inc 021-272003 Director
6.0 M
of 6.0 M
ORIG3N Inc 021-252675 Director
5.1 M
of 12.5 M
Clearside Biomedical Inc 021-252601 Director
14.4 M
of 20.0 M
PhaseBio Pharmaceuticals Inc 021-235733 Director
21.0 M
of 42.0 M
ORIG3N Inc 021-234278 Director
1.5 M
of 3.0 M
G1 Therapeutics Inc 021-233991 Director
16.5 M
of 33.0 M
Lysosomal Therapeutics Inc 021-233905 Director
26.1 M
of 26.1 M
Clearside Biomedical Inc 021-224726 Director
16.2 M
of 20.0 M
Clearside Biomedical Inc 021-217166 Director
3.0 M
of 6.0 M
G1 Therapeutics Inc 021-204775 Director
12.6 M
of 12.6 M
Genecentric Diagnostics Inc 021-198924 Director
5.0 M
of 5.0 M
Pathfinder Therapeutics Inc 021-198401 Director
1.2 M
of 1.8 M
G1 Therapeutics Inc 021-195183 Director
1.2 M
of 1.2 M
Clearside Biomedical Inc 021-191713 Director
7.9 M
of 8.5 M
Pathfinder Therapeutics Inc 021-178021 Director
5.3 M
of 9.2 M
Clearside Biomedical Inc 021-171400 Director
3.2 M
of 4.0 M
Artuslabs Inc 021-147436 Director 0.6 M
of 0.6 M
Artuslabs Inc 021-147437 Director 0.2 M
of 0.2 M
Artuslabs Inc 021-110610 Director 3.7 M
of 3.7 M
Pathfinder Therapeutics Inc 021-142634 Director 3.0 M
of 4.0 M
Cancerguide Diagnostics Inc 021-138168 Director 2.7 M
of 10.5 M
PhaseBio Pharmaceuticals Inc 021-40668 Director
48.5 M
of 48.5 M
Hatteras Venture Advisors VII LLC
Hatteras Opportunity Fund I LP 021-472491 Executive Officer
26.0 M
of 125.0 M		 32.6 M
Hatteras Venture Partners VII LP 021-472476 Executive Officer
135.1 M
of 250.0 M		 175.8 M
Hatteras Venture Advisors VI LLC
Hatteras Venture Partners VI LP 021-337301 Executive Officer
137.3 M
of 250.0 M		 123.9 M
Hatteras Venture Advisors V LLC
Hatteras Venture Partners V LP 021-246318 Executive Officer
91.1 M
of 150.0 M		 100.9 M
Hatteras Venture Advisors IV LLC
Hatteras NC Fund LP 021-164902 Executive Officer
74.9 M
of 125.0 M		 8.4 M
Hatteras Venture Partners IV LP 021-164902 Executive Officer
74.9 M
of 125.0 M		 43.2 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com